[HTML][HTML] Microsomal Triglyceride Transfer Protein: SPECIFICITY OF LIPID BINDING AND TRANSPORT (∗)

…, JK Dickson, CH Chu, MW Lago, JK Rinehart… - Journal of Biological …, 1995 - ASBMB
Microsomal triglyceride transfer protein (MTP) is a lipid transfer protein that is required for
the assembly and secretion of very low density lipoproteins by the liver and chylomicrons by …

Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus

…, GS Bisacchi, P Egli, JK Rinehart… - Antimicrobial agents …, 1999 - Am Soc Microbiol
BMS-200475 was recently shown to have potent antiviral activity against hepatitis B virus (50%
effective concentration = 3.7 nM; 50% cytotoxic concentration = 30 μM). In metabolic …

Orally active squalene synthase inhibitors: bis ((acyloxy) alkyl) prodrugs of the α-phosphonosulfonic acid moiety

…, DC Hsieh, SJ Lan, JK Rinehart… - Journal of medicinal …, 1996 - ACS Publications
R-phosphonosulfonic acids (R-PSAs) are potent inhibitors of squalene synthase in vitro. A
number of these inhibitors exhibited promising in vivo activity on intravenous dosing. However…

α-Phosphonosulfonic acids: potent and selective inhibitors of squalene synthase

…, DC Hsieh, SJ Lan, JK Rinehart… - Journal of medicinal …, 1996 - ACS Publications
Inhibitors of squalene synthase have recently received considerable attention in the search
for new antihypercholesterolemic agents. 1 We disclose herein the discovery of a new family …

Protein covalent binding of maxipost through a cytochrome P450-mediated ortho-quinone methide intermediate in rats

…, R Dai, M Zhu, JK Rinehart, L Klunk, J Mitroka - Drug metabolism and …, 2003 - ASPET
(3S)-(+)-(5-Chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indole-2-one)
(MaxiPost, BMS-204352) is a potent and specific opener for maxi-K channels and has …

Metabolism of [14C] gemopatrilat after oral administration to rats, dogs, and humans

…, M Jemal, S Khan, SJ Bonacorsi, JK Rinehart… - Drug metabolism and …, 2006 - ASPET
This study describes the pharmacokinetic parameters of gemopatrilat, a potent vasopeptidase
inhibitor, in humans and the comparative biotransformation of the compound in rats, dogs, …

Synthesis of multi‐labeled [14C]Aripiprazole

…, SC Waller, J Kent Rinehart - Journal of Labelled …, 2006 - Wiley Online Library
Abstract Development of Aripiprazole as an oral treatment of schizophrenia required the
synthesis of a suitably labeled drug product for use in human metabolism and pharmacokinetic …

Metabolism of [14C] omapatrilat, a sulfhydryl-containing vasopeptidase inhibitor in humans

…, B Malhotra, S Bonacorsi, SC Waller, JK Rinehart… - Drug metabolism and …, 2001 - ASPET
Omapatrilat, a potent vasopeptidase inhibitor, is currently under development for the treatment
of hypertension and congestive heart failure. This study describes the plasma profile …

Synthesis of the anxiolytic agent [14C] 6‐hydroxy‐buspirone for use in a human ADME study

…, GM Luke, JS Depue, J Kent Rinehart… - Journal of Labelled …, 2007 - Wiley Online Library
A reliable synthesis of 14 C labeled 6‐hydroxy‐buspirone is described. The molecule belongs
to a unique class of compounds with the potential for anxiolytic activity. A radiolabeled …

1, 3-Bridged aromatic systems. V. Strained aromatic systems

…, CT Hughes, MK Meilahn, JK Rinehart - The Journal of …, 1970 - ACS Publications
1, 3-Bridged naphthalenes of type 3 and 4, in which the minimum value of n is 2, have been
prepared in high yield, Steric constraint in such metacyclophanes causes distortion or …